Opiant Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Industry
Pharmaceutical Preparations
Location
233 Wilshire Blvd, Suite 400, Santa Monica, CA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Opiant Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Gorman General Counsel Mar 2, 2023
Michael Sinclair Director, 10%+ Owner Mar 2, 2023
Richard J. Daly Director Mar 2, 2023
Gabrielle A. Silver Director Mar 2, 2023
Ann L. MacDougall Director Mar 2, 2023
Masuoka K. Lorianne Director Mar 2, 2023
Matthew Ruth Chief Commercial Officer Mar 2, 2023
David D. O'Toole Chief Financial Officer Mar 2, 2023
Phil Skolnick Chief Scientific Officer Mar 2, 2023
Thomas T. Thomas Director Mar 2, 2023
Craig Collard Director Mar 2, 2023
Roger Crystal Chief Executive Officer, Director, 10%+ Owner Mar 2, 2023
Mark Jason Heath Ellison Chief Development Officer Mar 2, 2023

Recent Insider Transactions by Companies or Individuals for Opiant Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.